Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
70726-0303-1 · Riluzole Oral Suspension · EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)
What is the package ndc for 70726-0303-1 · Riluzole Oral Suspension · EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)?
For 70726-0303-1 · Riluzole Oral Suspension · EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.), package ndc is 70726-0303-1; generic name is Riluzole Oral Suspension; manufacturer is EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.); status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.
"initial_posting_date": "01/26/2024", "package_ndc": "70726-0303-1", "generic_name": "Riluzole Oral Suspension", "contact_info": "610-937-6172", "availability": "Unavailable", "related_info": "Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to testing"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 70726-0303-1 verified
- Generic name
- Riluzole Oral Suspension verified
- Manufacturer
- EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to testing verified
- Initial posting date
- 01/26/2024 verified
- Last update date
- 08/17/2026 verified
- Days in shortage
- 949 our reading
- Reason for shortage
- Requirements related to complying with good manufacturing practices verified
- Dosage form
- Oral Suspension verified
- Therapeutic category
- Neurology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/17/2026", "therapeutic_category": [ "Neurology" ], "dosage_form": "Oral Suspension", "presentation": "Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)", "company_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)", "shortage_reason": "Requirements related to complying with good manufacturing practices", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000